Back to top

Image: Bigstock

Make the Most of Your Retirement with These Top-Ranked Mutual Funds

Read MoreHide Full Article

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.

How can you tell a good mutual fund from a bad one? It's pretty basic: if the fund is diversified, has low fees, and shows strong performance, it's a keeper. Of course, there's a wide range, but using the Zacks Mutual Fund Rank, we've found three mutual funds that would be great additions to any long-term retirement investors' portfolios.

Let's learn about some of Zacks' highest ranked mutual funds with low fees you may want to consider.

If you are looking to diversify your portfolio, consider JPMorgan Intrepid Growth Fund R5 (JGIRX - Free Report) . JGIRX is a part of the Large Cap Growth mutual fund category, which invest in many large U.S. companies that are expected to grow much faster compared to other large-cap stocks. This fund is a winner, boasting an expense ratio of 0.44%, management fee of 0.3%, and a five-year annualized return track record of 11.3%.

T. Rowe Price Health Sciences (PRHSX - Free Report) is a stand out amongst its peers. PRHSX is part of the Sector - Health category, offering investors a focus on the healthcare industry, one of the largest sectors in the American economy. With five-year annualized performance of 10.27%, expense ratio of 0.8% and management fee of 0.63%, this diversified fund is an attractive buy with a strong history of performance.

GMO Quality III (GQETX - Free Report) . Expense ratio: 0.49%. Management fee: 0.48%. Five year annual return: 12.91%. GQETX is part of the Large Cap Blend section, and these mutual funds most often invest in firms with a market capitalization of $10 billion or more. By investing in bigger companies, these funds offer more stability, and are often well-suited for investors with a "buy and hold" mindset.

There you have it. If your financial advisor had you put your money into any of our top-ranked funds, then they've got you covered. If not, you may need to talk.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


T. Rowe Price Health Sciences (PRHSX) - free report >>

JPMorgan US GARP Equity R5 (JGIRX) - free report >>

GMO Quality III (GQETX) - free report >>

Published in